Search Results - "Kiang, Tony K.L."
-
1
Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology
Published in Pharmaceutics (11-10-2017)“…While therapeutic drug monitoring (TDM) that uses blood as the biological matrix is the traditional gold standard, this practice may be impossible,…”
Get full text
Journal Article Book Review -
2
Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study
Published in American journal of health-system pharmacy (15-03-2018)“…PURPOSE.Results of a study comparing testosterone exposure and tolerability with subcutaneous versus i.m. administration are presented. METHODS.In a…”
Get full text
Journal Article -
3
Population pharmacokinetics of mycophenolic acid in paediatric patients
Published in British journal of clinical pharmacology (01-04-2021)“…Mycophenolic acid (MPA) is widely used in paediatric kidney transplant patients and sometimes prescribed for additional indications. Population pharmacokinetic…”
Get full text
Journal Article -
4
Characterization of human sulfotransferases catalyzing the formation of p-cresol sulfate and identification of mefenamic acid as a potent metabolism inhibitor and potential therapeutic agent for detoxification
Published in Toxicology and applied pharmacology (15-08-2021)“…p-Cresol sulfate, the primary metabolite of p-cresol, is a uremic toxin that has been associated with toxicities and mortalities. The study objectives were to…”
Get full text
Journal Article -
5
Characterizations of Human UDP-Glucuronosyltransferase Enzymes in the Conjugation of p-Cresol
Published in Toxicological sciences (01-08-2020)“…Abstract p-Cresol is a uremic toxin that is formed by intestinal microbiota and extensively conjugated by first-pass metabolism. p-Cresol glucuronide exerts…”
Get full text
Journal Article -
6
Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling
Published in Clinical pharmacokinetics (01-09-2023)“…Background and Objectives Mycophenolic acid (MPA) is an immunosuppressant commonly prescribed in pediatric kidney transplantation to prevent graft rejection…”
Get full text
Journal Article -
7
Mechanisms of Metabolism Interaction Between p-Cresol and Mycophenolic Acid
Published in Toxicological sciences (01-02-2020)“…Abstract Mycophenolic acid (MPA) is commonly prescribed for preventing graft rejection after kidney transplantation. The primary metabolic pathways of MPA are…”
Get full text
Journal Article -
8
Recent lessons learned from population pharmacokinetic studies of mycophenolic acid: physiological, genomic, and drug interactions leading to the prediction of drug effects
Published in Expert opinion on drug metabolism & toxicology (02-12-2021)“…Mycophenolic acid (MPA) is a widely used immunosuppressant in transplantation and autoimmune disease. Highly variable pharmacokinetics have been observed with…”
Get more information
Journal Article -
9
Population Pharmacokinetics of Mycophenolic Acid: An Update
Published in Clinical pharmacokinetics (01-05-2018)“…The most recent comprehensive reviews on the population pharmacokinetics of mycophenolic acid (MPA) were published in 2014. Since then, several population…”
Get full text
Journal Article -
10
Bioavailability and Metabolism of Bioactive Peptide IRW with Angiotensin-Converting Enzyme 2 (ACE2) Upregulatory Activity in Spontaneously Hypertensive Rats
Published in Journal of agricultural and food chemistry (17-04-2024)“…Peptide IRW is the first food-derived angiotensin-converting enzyme 2 (ACE2) upregulator. This study aimed to investigate the pharmacokinetic characteristics…”
Get full text
Journal Article -
11
Population Pharmacokinetics of Mycophenolic Acid Co-Administered with Tacrolimus in Corticosteroid-Free Adult Kidney Transplant Patients
Published in Clinical pharmacokinetics (01-11-2019)“…Background and Objective Mycophenolic acid is commonly prescribed to adult kidney transplant recipients. Mycophenolic acid is extensively metabolized to…”
Get full text
Journal Article -
12
Exposure-Toxicity Relationships of Mycophenolic Acid in Adult Kidney Transplant Patients
Published in Clinical pharmacokinetics (01-12-2019)“…Mycophenolic acid is commonly prescribed in adult kidney transplant recipients for preventing graft rejection. A therapeutic target for total mycophenolic acid…”
Get full text
Journal Article -
13
UDP-glucuronosyltransferases and clinical drug-drug interactions
Published in Pharmacology & therapeutics (Oxford) (01-04-2005)“…UDP-glucuronosyltransferase (UGT) enzymes catalyze the conjugation of various endogenous substances (e.g., bilirubin) and exogenous compounds (e.g., drugs)…”
Get full text
Journal Article -
14
Significant Correlations between p-Cresol Sulfate and Mycophenolic Acid Plasma Concentrations in Adult Kidney Transplant Recipients
Published in Clinical drug investigation (01-03-2022)“…Background and Objectives Mycophenolic acid (MPA) is a commonly prescribed life-long immunosuppressant for kidney transplant recipients. The frequently…”
Get full text
Journal Article -
15
Development and validation of a sensitive liquid‐chromatography tandem mass spectrometry assay for mycophenolic acid and metabolites in HepaRG cell culture: Characterization of metabolism interactions between p‐cresol and mycophenolic acid
Published in Biomedical chromatography (01-08-2019)“…Mycophenolic acid (MPA), a frequently used immunosuppressant, exhibits large inter‐patient pharmacokinetic variability. This study (a) developed and validated…”
Get full text
Journal Article -
16
A Critical Review on the Clinical Pharmacokinetics, Pharmacodynamics, and Clinical Trials of Ceftaroline
Published in Clinical pharmacokinetics (01-09-2015)“…Only a parenteral formulation of ceftaroline is commercially available, and the prodrug, ceftaroline fosamil, is hydrolyzed quickly and completely upon…”
Get full text
Journal Article -
17
Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy
Published in European journal of drug metabolism and pharmacokinetics (01-01-2021)“…The objectives of this qualitative review were to critically evaluate and summarize the currently available data on the use of anti-tuberculosis (TB) drugs…”
Get full text
Journal Article -
18
Effects of p-Cresol on Oxidative Stress, Glutathione Depletion, and Necrosis in HepaRG Cells: Comparisons to Other Uremic Toxins and the Role of p-Cresol Glucuronide Formation
Published in Pharmaceutics (09-06-2021)“…The toxicological effects of p-cresol have primarily been attributed to its metabolism products; however, very little human data are available in the key organ…”
Get full text
Journal Article -
19
Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization
Published in European journal of drug metabolism and pharmacokinetics (01-08-2019)“…Several HepaRG three-dimensional (3D) in vitro model systems have been developed to improve the predictability of xenobiotic metabolism and toxicity. In this…”
Get full text
Journal Article -
20
Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software
Published in Clinical pharmacokinetics (01-08-2012)“…Population pharmacokinetic modelling is widely used within the field of clinical pharmacology as it helps to define the sources and correlates of…”
Get full text
Journal Article